- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Rare case of Iatrogenic endometriosis reported
Dr Alkan Cubuk at Department of Urology, Kartal Dr Lütfi Kırdar Training and Research Hospital, Istanbul, Turkey and colleagues have reported a rare case of iatrogenic endometriosis following apical pelvic organ prolapse surgery. The case has appeared in the Journal of Medical Case Reports.
Iatrogenic endometriosis is the presence of endometrial glands and stroma out of the uterus following certain surgical interventions. The rate of iatrogenic endometriosis after gynecologic surgeries due to benign uterine disease is 1–2%.
A 46-year-old parous Slavic woman who underwent LASH secondary to grade 3 symptomatic apical prolapse 1 year ago was admitted to our clinic with pelvic pain that had started 6 months following surgery. It worsened with sexual intercourse and was not relieved with oral analgesic drugs. She had no complaints of urinary incontinence or prolapse. She did not have any remarkable bladder or bowel symptoms. On physical examination with a vaginal speculum, pain upon deep vaginal palpation was detected, but there was no sign of erosion on the cervix and vaginal wall. Transvaginal ultrasonography (US) revealed a hypoechogenic and hypervascular solid area with irregular contours sized 3 × 2 cm in diameter on the sacral promontory. The transabdominal US showed normal kidneys and ureters with normal peristalsis. A flexible cystoscopy and office-based rectosigmoidoscopy were performed to exclude any reason for pelvic pain. No further abnormal findings were observed in the bladder and rectosigmoid area. The patient was reluctant to undergo further diagnostic imaging such as pelvic magnetic resonance imaging (MRI) because of her insurance status. After discussing the diagnostic possibilities with the patient, she was scheduled for diagnostic laparoscopy.
Surgical technique
Informed consent was obtained from the patient preoperatively. After the administration of general anaesthesia and antibiotic prophylaxis, the patient was placed in the Trendelenburg position. A Veress needle was used to achieve pneumoperitoneum. Previous trocar sites were used for laparoscopic port placement; a 12-mm port was placed at the inferior margin of the umbilicus, and 5-mm ports were placed medially to iliac spine on both sides. After the port placement, adhesions secondary to the previous surgery were excised. The position of the mesh under peritoneum from promontory to cervical uteri was totally normal. No abnormalities were detected regarding ureters.
The only pathologic finding was detected on the peritoneum covering the sacral promontory: a 2 × 2-cm, solid, wine-coloured, hypervascular hemorrhagic lesion, which macroscopically resembled endometriosis (Fig. 1). The lesion and the peritoneal layer behind it were totally excised (Fig. 2). There was no sign of invasion to the deeper parts of the pelvic wall and organs. The abdominal cavity was checked for other potential focal lesions of endometriosis and washed out with saline. After hemostasis was achieved using bipolar cautery and applying hemostatic agents, the procedure was terminated (Fig. 3). The patient was discharged on the first postoperative day, without any complications.
Pathologic examination revealed foci of endometriosis comprising endometrial glands and stroma within the connective tissue, along with hemosiderin-laden macrophages. The patient was classified as having stage 1 disease (a minimal disease with few implants on the peritoneum) according to the American Society for Reproductive Medicine and category 1 (peritoneal endometriosis) according to the Endometriosis Foundation of America. The symptoms of the patient resolved, and no adjuvant treatment was needed up to 1 year after surgery. A clinical visit including physical examination and US assessment was planned for every 6 months as a follow-up.
Journal Information: Journal of Medical Case Reports
For more details click on the link: https://doi.org/10.1186/s13256-019-2327-x
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd